Matches in Nanopublications for { ?s ?p "[Expression of MYB is controlled, in breast cancer and other cell types, by a transcriptional pausing mechanism involving an attenuation site located ?1.7?kb downstream from the transcription start site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP594424.RApYvZghfpyQFmSdnr_SNiBaUhCLM9kjiFb5hemVnavqw130_assertion description "[Expression of MYB is controlled, in breast cancer and other cell types, by a transcriptional pausing mechanism involving an attenuation site located ?1.7?kb downstream from the transcription start site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP594424.RApYvZghfpyQFmSdnr_SNiBaUhCLM9kjiFb5hemVnavqw130_provenance.
- NP816035.RAhHHfJlVzSYZMyfHcmBLcwyusnxsE0sI5WezUYsDGsOk130_assertion description "[Expression of MYB is controlled, in breast cancer and other cell types, by a transcriptional pausing mechanism involving an attenuation site located ?1.7?kb downstream from the transcription start site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP816035.RAhHHfJlVzSYZMyfHcmBLcwyusnxsE0sI5WezUYsDGsOk130_provenance.
- assertion description "[Expression of MYB is controlled, in breast cancer and other cell types, by a transcriptional pausing mechanism involving an attenuation site located ?1.7?kb downstream from the transcription start site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Expression of MYB is controlled, in breast cancer and other cell types, by a transcriptional pausing mechanism involving an attenuation site located ?1.7?kb downstream from the transcription start site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP973856.RARxJe2HNIghmDENrBfWCZOo71rVAlf4IruOKObCYGIxI130_assertion description "[Expression of MYB is controlled, in breast cancer and other cell types, by a transcriptional pausing mechanism involving an attenuation site located ?1.7?kb downstream from the transcription start site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973856.RARxJe2HNIghmDENrBfWCZOo71rVAlf4IruOKObCYGIxI130_provenance.
- NP973859.RAQfooabRE-PnBMaBOErjNBuMIeppuwaG_TSnuvEqo4yE130_assertion description "[Expression of MYB is controlled, in breast cancer and other cell types, by a transcriptional pausing mechanism involving an attenuation site located ?1.7?kb downstream from the transcription start site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973859.RAQfooabRE-PnBMaBOErjNBuMIeppuwaG_TSnuvEqo4yE130_provenance.
- NP580602.RAOfPu7jhGABu_PdDMrQYGHqsvJ47T2pCNpbAFJ5qVDrU130_assertion description "[Expression of MYB is controlled, in breast cancer and other cell types, by a transcriptional pausing mechanism involving an attenuation site located ?1.7?kb downstream from the transcription start site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580602.RAOfPu7jhGABu_PdDMrQYGHqsvJ47T2pCNpbAFJ5qVDrU130_provenance.
- NP580742.RAHotazMZf1QiOuOHC_S3urXs0vEEDOf5VwT5LDD4JmnA130_assertion description "[Expression of MYB is controlled, in breast cancer and other cell types, by a transcriptional pausing mechanism involving an attenuation site located ?1.7?kb downstream from the transcription start site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580742.RAHotazMZf1QiOuOHC_S3urXs0vEEDOf5VwT5LDD4JmnA130_provenance.